New device for high-throughput viability screening of flow biofilms.
Kirk Jensen
Jan 3, 2017 11:04:32 AM
At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Kirk Jensen
Jan 3, 2017 11:04:32 AM